Mind Medicine, Inc.’s $500 Million Base Shelf Prospectus

Cassels acted for MindMed on the operation.

On April 9, 2021, Mind Medicine (MindMed) Inc. filed a short form base shelf prospectus with securities regulators in each of the provinces and territories of Canada and a corresponding registration statement on Form F-10 with the United States Securities and Exchange Commission in accordance with the Multijurisdictional Disclosure System established between Canada and the United States.

The base shelf prospectus and registration statement will permit MindMed to offer and sell subordinate voting shares, multiple voting shares, warrants, subscription receipts, units or any combination thereof in various offerings having an aggregate value of up to $500 million during the 25-month period that the base shelf prospectus remains effective.

The Cassels team comprised of Jonathan Sherman (Picture), Jamie Litchen and David Singh (Securities).


Involved fees earner: Jamie Litchen – Cassels Brock & Blackwell LLP; Jonathan Sherman – Cassels Brock & Blackwell LLP; David Singh – Cassels Brock & Blackwell LLP;

Law Firms: Cassels Brock & Blackwell LLP;

Clients: Mind Medicine Inc;

Print Friendly, PDF & Email
Martina Bellini

Author: Martina Bellini